28
Participants
Start Date
September 14, 2022
Primary Completion Date
May 31, 2028
Study Completion Date
October 31, 2028
Vincristine
IV, D1-D22-D43 and D64
Irinotecan
Oral, 5 days/week during W1,W2,W7 and W8 (D1 to D5, D8 to D12, D43 to D47, D50 to D54)
Temozolomide
Oral,3 weeks in a row, twice per cycle (D1 to D21, D43 to D63)
Etoposide
Oral, 3 weeks in a row, twice per cycle (D22 to D42, D64 to D84)
Cis-Retinoic acid
Oral, 2 weeks in a row, thrice per cycle (D15 to D28, D43 to D56, D71 to D84)
RECRUITING
"Hôpital pour Enfants La Timone AP-HM", Marseille
RECRUITING
CHRU de Bordeaux Hôpital des Enfants, Bordeaux
NOT_YET_RECRUITING
CHU de MONTPELLIER - Hôpital Arnaud de Villeneuve, Montpellier
RECRUITING
CHU Hôpital Sud, Rennes
RECRUITING
CHU GRENOBLE ALPES - Hôpital COUPLE ENFANT, Grenoble
RECRUITING
CHU Nantes, Nantes
RECRUITING
CHRU NANCY - Hôpital d'Enfants, Vandœuvre-lès-Nancy
RECRUITING
Centre Oscar Lambret, Lille
RECRUITING
CHRU Strasbourg - Hôpital de Hautepierre, Strasbourg
RECRUITING
Centre Léon Bérard, Lyon
RECRUITING
CHU Toulouse - Hôpital des Enfants, Toulouse
RECRUITING
Hôpital Armand-TROUSSEAU, Paris
RECRUITING
Chu Rouen, Rouen
NOT_YET_RECRUITING
CHU Amiens Picardie, Amiens
RECRUITING
Gustave ROUSSY, Villejuif
RECRUITING
CHU de Besancon, Besançon
NOT_YET_RECRUITING
CHU La Réunion, Saint-Denis
RECRUITING
CHU de Nice - Hôpital Archet 2, Nice
Centre Oscar Lambret
OTHER